Skip to main content
. Author manuscript; available in PMC: 2024 Mar 14.
Published in final edited form as: Urol Oncol. 2022 Oct 26;41(1):51.e25–51.e31. doi: 10.1016/j.urolonc.2022.08.013

Table 2.

Multivariable model evaluating risk of death among the entire patient cohort.

Feature Hazard ratio 95% Confidence ratio P Value
Cytoreductive nephrectomy 0.33 0.24–0.45 <0.0001
Histology
 Clear cell 1.0 (reference) - -
 Non-clear cell 2.08 1.37–3.15 0.001
 Other/Unknown 1.61 1.08–2.39 0.02
Total metastatic sites
 Only 1 1.0 (reference) - -
 2 or more 1.09 0.81–1.47 0.6
Age at metastatic diagnosis 1.00 0.99–1.02 0.7
IMDC risk score
 Favorable 1.0 (reference) - -
 Intermediate 1.24 0.65–2.38 0.5
 Poor 2.28 1.13–4.61 0.02
ICI utilization
 First line 1.0 (reference)
 Second line or later 1.03 0.7–1.53 0.9